Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [1876]
News [4315]
Articles [404]
Editorials [10]
Conferences [107]
elearning [41]
Targeting the PI3K/mTOR pathway
Dr Lewis Cantley – Dana-Farber Cancer Institute, Boston, USA
Targeting the PI3K/mTOR pathway ( Dr Lewis Cantley – Dana-Farber Cancer Institute, Boston, USA )
17 May 2012
Use of metformin against breast cancer
Prof Alastair Thompson – University of Dundee, UK
Use of metformin against breast cancer ( Prof Alastair Thompson – University of Dundee, UK )
17 May 2012
Cancer genes differ in different parts of a tumour
Prof Charles Swanton - CRUK London Research Institute and UCL, UK
Cancer genes differ in different parts of a tumour ( Prof Charles Swanton - CRUK London Research Institute and UCL, UK )
17 May 2012
Targeting DNA damage response and repair excluding PARP for triple negative...
Prof Thomas Helleday - Karolinska Institutet, Stockholm, Sweden
Targeting DNA damage response and repair excluding PARP for triple negative breast cancer ( Prof Thomas Helleday - Karolinska Institutet, Stockholm, Sweden )
17 May 2012
Molecular characterisation of breast cancer: the mutational landscape
Prof Sam Aparicio - University of British Columbia, Vancouver, Canada
Molecular characterisation of breast cancer: the mutational landscape ( Prof Sam Aparicio - University of British Columbia, Vancouver, Canada )
17 May 2012
New cyclin-dependent kinase inhibitor with letrozole for ER+/HER2- breast cancer
Prof Richard Finn - Universtity of California, Los Angeles, USA
New cyclin-dependent kinase inhibitor with letrozole for ER+/HER2- breast cancer ( Prof Richard Finn - Universtity of California, Los Angeles, USA )
17 May 2012
Metabolism in malignant tumors: a new approach for treating breast cancer
Prof Tak Mak - University of Toronto, Canada
Metabolism in malignant tumors: a new approach for treating breast cancer ( Prof Tak Mak - University of Toronto, Canada )
17 May 2012
Criteria required before implementation of whole genome arrays in clinical...
Prof Daniel Hays - University of Michigan, Ann Arbor, USA
Criteria required before implementation of whole genome arrays in clinical practice ( Prof Daniel Hays - University of Michigan, Ann Arbor, USA )
17 May 2012
Evidence for TORC1 activation marker as a predictive factor for everolimus...
Dr Thomas Bachelot - Centre Leon Berard, Lyon, France
Evidence for TORC1 activation marker as a predictive factor for everolimus efficacy in metastatic breast cancer ( Dr Thomas Bachelot - Centre Leon Berard, Lyon, France )
17 May 2012
Prognostic significance of progesterone receptor-positive tumour cells within...
Dr Aleix Prat - University of North Carolina, USA
Prognostic significance of progesterone receptor-positive tumour cells within luminal A breast cancer ( Dr Aleix Prat - University of North Carolina, USA )
17 May 2012
EONS 2012 lifetime achievement award
Nurgün Platin – Oncology Nursing Association, Turkey
EONS 2012 lifetime achievement award ( Nurgün Platin – Oncology Nursing Association, Turkey )
11 May 2012
Impact and management of malignant wounds
Dr Betina Lund-Nielsen - University of Copenhagen, Denmark
Impact and management of malignant wounds ( Dr Betina Lund-Nielsen - University of Copenhagen, Denmark )
10 May 2012

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation